Corcept Therapeutics Incorporated
(CORT - NASDAQ)
45,88 USD
📋 Profilo Aziendale

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States.

|